| 1021/2267 | US=22 / Urologia Reckamp KL, Figlin RA, Strieter RM. Chemokines in renal cell carcinoma: implications for tumor angiogenesis and metastasis. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 249-65. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; QUIMIOCINAS; ANGIOGENESE; POTENCIAL METASTATICO; TRATAMENTO |
| 1022/2267 | US=22 / Urologia Cho D, Mier JW, Atkins MB. PI3K/AKt/mTOR pathway: a growth and proliferation pathway. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 267-85. ISBN 978-1-58829-737-2. INIBIDORES PI3K; RCC; HIPERATIVACAO DO AKT/PI3K; ATIVIDADE AKT; TEMSIROLIMUS |
| 1023/2267 | US=22 / Urologia Jonasch E, Walker CL. EGFR and HER2: relevance in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 287-303. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; ERBB; TERAPIA-ALVO; RESISTENCIA; SINALIZACAO |
| 1024/2267 | US=22 / Urologia Garcia JA, Varizi SJA, Ganapathi R. Proteasome-NFkB signaling pathway: relevance in RCC. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 305-20. ISBN 978-1-58829-737-2. SISTEMA UBIQUITINA-PROTEASSOMA; VIA DE PROTEASSOMA NA RCC; INIBICAO DO PROTEASSOMA |
| 1025/2267 | US=22 / Urologia Peruzzi B, Lattouf JB, Bottaro DP. The role of hepatocyte growth factor pathway signaling in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 321-34. ISBN 978-1-58829-737-2. FATOR DE CRESCIMENTO HEPATOCITO; C-MET; CARCINOMA DE CELULAS RENAIS; MECANISMOS ONCOGENICOS; DESENVOLVIMENTO DROGA CONTRA O CANCER |
| 1026/2267 | US=22 / Urologia Mizutani Y, kawauchi A, Bonavida B, Miki T. Smac/DIABLO: a proapoptotic molecular target in renal cell cancer. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 335-46. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; SMAC / DIABLO; PROGNOSTICO; APOPTOSE; CISPLATINA; XIAP; RCC; TRAIL |
| 1027/2267 | US=22 / Urologia Kawabe M, Herrem CJ, Finke JH, Storkus WJ. EphA2: a novel target in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 347-66. ISBN 978-1-58829-737-2. RTK; CD8+ T LINFOCITOS; QUINASE DE TIROSINA RECEPTORA; PROTEASSOMA; TERAPIA COMBINATORIA; COMPLEXO PRINCIPAL DE HISTOCOMPATIBILIDADE |
| 1028/2267 | US=22 / Urologia Inman BA, Frigola X, Dong H, Yang JC, Kwon ED. Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 367-403. ISBN 978-1-58829-737-2. COESTIMULACAO; INIBICAO; IMUNOLOGIA DE TUMORES; IMMUNOEDITING; IMUNOTERAPIA; LINFOCITOS T; CARCINOMA DE CELULAS RENAIS |
| 1029/2267 | US=22 / Urologia Shaheen PE, Bukowski RM, Finke JH. The role of gangliosides in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 405-23. ISBN 978-1-58829-737-2. GANGLIOSIDEOS NA RCC; GLICOESFINGOLIPIDOS; GANGLIOSIDOS E VEGF; GANGLIOSIDEOS COMO ALVOS TERAPEUTICOS |
| 1030/2267 | US=22 / Urologia Parton M, Das T, Sa G, Finke J, Eisen T, Tannenbaum C. Tumour necrosis factor - misnomer and therapeutic target. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 425-48. ISBN 978-1-58829-737-2. FATOR DE NECROSE TUMORAL; CITOCINA; IMUNOMODULACAO; ANGIOGENESE; FATOR DE CRESCIMENTO |
| 1031/2267 | US=22 / Urologia Nogueira M, Kim HL. Molecular markers for predicting prognosis of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 449-71. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; MARCADORES MOLECULARES; PROGNOSTICO |
| 1032/2267 | US=22 / Urologia Kadar AK, Wood CG. Adjuvant therapy for renal cell carcinoma: targeted approaches. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 473-95. ISBN 978-1-58829-737-2. TERAPIA ADJUVANTE; CARCINOMA DE CELULAS RENAIS; DOENCA LOCALMENTE AVANCADA |
| 1033/2267 | US=24 / Patologia Rosen PP. Intraductal carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 285-357. ISBN 978-0-7817-7137-5. MAMA; CARCINOMA INTRADUCTAL; CARCINOMA INTRADUCTAL PALPAVEL; ANGIOGENESE; RECEPTORES HORMONAIS; ONCOGENE; TAXA DE PLOIDIA; PROLIFERACAO CELULAR; CITOGENETICA; GENETICA MOLECULAR; BIOPSIA POR AGULHA; LINFONODO SENTINELA |
| 1034/2267 | US=24 / Patologia Rosen PP. Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 358-404. ISBN 978-0-7817-7137-5. MAMA; CARCINOMA INVASIVO; NECROSE; APOPTOSE; TELOMERASE; EMBOLOS TUMORAIS LINFATICOS; INVASAO NEOPLASICA EM VASOS SANGUINEOS; ANGIOGENESE; INVASAO PERINEURAL; TAXA DE CRESCIMENTO DO TUMOR; MORFOMETRIA NUCLEAR; FENOTIPO BASAL |
| 1035/2267 | US=24 / Patologia Rosen PP. Tubular carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 405-22. ISBN 978-0-7817-7137-5. |
| 1036/2267 | US=24 / Patologia Rosen PP. Papillary carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 423-48. ISBN 978-0-7817-7137-5. |
| 1037/2267 | US=24 / Patologia Rosen PP. Medullary carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 449-69. ISBN 978-0-7817-7137-5. |
| 1038/2267 | US=24 / Patologia Rosen PP. Carcinoma with metaplasia. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 470-505. ISBN 978-0-7817-7137-5. |
| 1039/2267 | US=24 / Patologia Rosen PP. Squamous carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 506-14. ISBN 978-0-7817-7137-5. |
| 1040/2267 | US=24 / Patologia Rosen PP. Mucinous carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 515-35. ISBN 978-0-7817-7137-5. |